Blood Glucose Outcomes of Anti-Retroviral Therapy Naïve Ugandan People with HIV with Pre-Diabetes Mellitus Initiated on Dolutegravir for 48 Weeks
Roles
Author
Document Type
Article
Publication Date
1-1-2024
Publication Title
BMC Infectious Diseases
DOI
10.1186/s12879-024-09655-9
Recommended Citation
Mulindwa, F., Schwarz, J., Brusselaers, N., Nabwana, M., Bollinger, R. C., Buzibye, A., Amutuhaire, W., Yendewa, G. A., Laker, E. A., Kiguba, R., & Castelnuovo, B. (2024). Blood Glucose Outcomes of Anti-Retroviral Therapy Naïve Ugandan People with HIV with Pre-Diabetes Mellitus Initiated on Dolutegravir for 48 Weeks. BMC Infectious Diseases, 24 (1). https://doi.org/10.1186/s12879-024-09655-9
